Rizatriptan Benzoate Tablet
Product Images NDC 71205-644

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 71205-644). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Estimated Probability Of Achieving An Initial Headache Response By 2 Hours In Pooled Studies 1, 2, 3, And 4†† (Rizatriptan Fig1)

A Kaplan-Meier plot showing the estimated probability of achieving an initial headache response by 2 hours post-dose in pooled studies comparing placebo, Rizatriptan Benzoate 5 mg, and Rizatriptan Benzoate 10 mg. The graph plots time (hours post-dose) against estimated probability of response, illustrating higher probabilities for Rizatriptan Benzoate doses versus placebo in outpatient trials.*

FDA Label Image

Figure 2: Estimated Probability Of Patients Taking A Second Dose Of Rizatriptan Benzoate Tablets Or Other Medication For Migraines Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Studies 1, 2, 3, And 4††† (Rizatriptan Fig2)

Kaplan-Meier plot showing the estimated probability of patients taking a second dose of Rizatriptan Benzoate 5 mg, 10 mg, or placebo, or other medication for migraines over 24 hours post initial dose in pooled clinical studies. The y-axis indicates estimated probability of remedication or rescue, and the x-axis represents hours post-dose, with distinct lines for placebo, 5 mg, and 10 mg doses.*

FDA Label Image

Figure3 (Rizatriptan Fig3)

A line graph comparing the percent response over time (in hours after a stage 2 dose) between Rizatriptan Benzoate orally disintegrating tablets and placebo. The graph shows response percentages with error bars for both groups at 0.5, 1.0, 1.5, and 2.0 hours post-dose.*

FDA Label Image

71205-644-12 (Rizatriptan Fig5)

Label for Rizatriptan Benzoate 10 mg tablets by Proficient Rx LP. The label specifies a package of 12 tablets, describing each tablet as pale pink, circular, flat beveled-edge, uncoated, debossed with 'X' on one side and '14' on the other. Manufactured by Aurobindo Pharma Limited, Hyderabad, India, with storage instructions at 20°-25°C (68°-77°F). Contains barcodes, QR codes, and regulatory information including NDC 71205-644-12.*

FDA Label Image

Chemical Structure (Rizatriptan Str)

Chemical structure of Rizatriptan Benzoate, showing its complex aromatic and heterocyclic components, including an indole ring, methylated amine side chain, and benzoate moiety with a carboxyl functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.